Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benza

Showing results (281-290 of 361) with videos related to

Pageof 37
Sort By:
Pharmacogenetics and Genomics|April 6, 2022
Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertensionVasiliki Thomeas-McEwing, Mitchell A Psotka, Eric R Gamazon, et al.
Pulmonary Circulation|August 1, 2022
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluationDan Grinnan, Le Kang, Christine DeWilde, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 5, 2007
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysisMario Viganò, Murat Tuzcu, Raymond Benza, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2020
Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association RegistryJacqueline T DesJardin, Nicholas A Kolaitis, Noah Kime, et al.
The European Respiratory Journal|May 6, 2020
Risk stratification in pulmonary arterial hypertension using Bayesian analysisManreet K Kanwar, Mardi Gomberg-Maitland, Marius Hoeper, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Clinical risk factors for portopulmonary hypertensionSteven M Kawut, Michael J Krowka, James F Trotter, et al.
Cardiovascular Therapeutics|September 14, 2012
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertensionRobert C Bourge, Victor F Tapson, Zeenat Safdar, et al.
Chest|June 13, 2015
Five-Year outcomes of patients enrolled in the REVEAL RegistryHarrison W Farber, Dave P Miller, Abby D Poms, et al.
Chest|January 15, 2009
Serotonin transporter polymorphisms in patients with portopulmonary hypertensionKari E Roberts, Michael B Fallon, Michael J Krowka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2017
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertensionRoberto Badagliacca, Amresh Raina, Stefano Ghio, et al.
Pageof 37

Showing results (281-290 of 361) with videos related to

Sort By:
Pageof 37
Pharmacogenetics and Genomics|April 6, 2022
Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertensionVasiliki Thomeas-McEwing, Mitchell A Psotka, Eric R Gamazon, et al.
Pulmonary Circulation|August 1, 2022
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluationDan Grinnan, Le Kang, Christine DeWilde, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 5, 2007
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysisMario Viganò, Murat Tuzcu, Raymond Benza, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2020
Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association RegistryJacqueline T DesJardin, Nicholas A Kolaitis, Noah Kime, et al.
The European Respiratory Journal|May 6, 2020
Risk stratification in pulmonary arterial hypertension using Bayesian analysisManreet K Kanwar, Mardi Gomberg-Maitland, Marius Hoeper, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Clinical risk factors for portopulmonary hypertensionSteven M Kawut, Michael J Krowka, James F Trotter, et al.
Cardiovascular Therapeutics|September 14, 2012
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertensionRobert C Bourge, Victor F Tapson, Zeenat Safdar, et al.
Chest|June 13, 2015
Five-Year outcomes of patients enrolled in the REVEAL RegistryHarrison W Farber, Dave P Miller, Abby D Poms, et al.
Chest|January 15, 2009
Serotonin transporter polymorphisms in patients with portopulmonary hypertensionKari E Roberts, Michael B Fallon, Michael J Krowka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2017
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertensionRoberto Badagliacca, Amresh Raina, Stefano Ghio, et al.
Pageof 37